Stock Events

Stock Events

Clearside Biomedical 

$0.125000
40
-$0.13-50% Thursday 13:50

Statistics

Day High
0.31
Day Low
0.31
52W High
13.27
52W Low
0.01
Volume
106
Avg. Volume
9,765
Mkt Cap
654,250
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14MayExpected
Q4 0
Q3 2025
Q1 2026
-1.35
-1.1
-0.85
-0.6
Expected EPS
-1.35
Actual EPS
N/A

Financials

-2,064.42%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
1.66MRevenue
-34.35MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLSDQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
EyePoint
EYPT
Mkt Cap1.21B
EyePoint Pharmaceuticals focuses on developing treatments for eye diseases, directly competing with Clearside's ocular therapies.
Bausch Health Companies
BHC
Mkt Cap1.83B
Bausch Health Companies, through its eye health division, competes in developing treatments for various eye conditions.
Novartis
NVS
Mkt Cap305.1B
Novartis offers a broad portfolio of drugs, including treatments for eye diseases, competing on a global scale.
Regenxbio
RGNX
Mkt Cap686.54M
REGENXBIO's focus on AAV gene therapies for retinal diseases puts it in direct competition with Clearside's eye disease treatments.
Ocular Therapeutix
OCUL
Mkt Cap2.11B
Ocular Therapeutix develops innovative therapies for eye diseases, competing in the ocular drug delivery space.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline, with its broad pharmaceutical portfolio, includes treatments for eye conditions, making it a competitor in the broader pharmaceutical market.

About

Clearside Biomedical, Inc. operates as a biopharmaceutical company, specializing in novel approaches to administer therapies to the posterior region of the eye via the suprachoroidal space. Its market-approved product, XIPERE, is an injectable suspension containing triamcinolone acetonide, utilized to manage macular edema associated with uveitis. Additionally, the firm is progressing CLS-AX, an axitinib injectable suspension intended for suprachoroidal injection, having concluded its Phase 2 clinical trial for the treatment of wet age-related macular degeneration (AMD). Strategic collaborations are in place with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Founded in 2011 and headquartered in Alpharetta, Georgia, Clearside Biomedical regrettably initiated Chapter 11 reorganization proceedings by filing a voluntary petition with the U.S. Bankruptcy Court for the District of Delaware on November 23, 2025.
Show more...
CEO
Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Employees
32
Country
United States
ISIN
US1850632035

Listings

MU
DE
CLM0.MU
STU
DE
CLM0.STU
STU
DE
CLM.STU
OTC Link
US
CLSDQ

0 Comments

Share your thoughts

FAQ

What is Clearside Biomedical stock price today?▼
The current price of CLSDQ is $0.13 USD — it has decreased by -50% in the past 24 hours. Watch Clearside Biomedical stock price performance more closely on the chart.
What is Clearside Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Clearside Biomedical stocks are traded under the ticker CLSDQ.
Is Clearside Biomedical stock price growing?▼
CLSDQ stock has risen by +0% compared to the previous week, the month change is a -58.33% fall, over the last year Clearside Biomedical has showed a -99.05% decrease.
What is Clearside Biomedical market cap?▼
Today Clearside Biomedical has the market capitalization of 654,250
What is Clearside Biomedical revenue for the last year?▼
Clearside Biomedical revenue for the last year amounts to 1.66M USD.
What is Clearside Biomedical net income for the last year?▼
CLSDQ net income for the last year is -34.35M USD.
How many employees does Clearside Biomedical have?▼
As of July 10, 2026, the company has 32 employees.
In which sector is Clearside Biomedical located?▼
Clearside Biomedical operates in the Other sector.
When did Clearside Biomedical complete a stock split?▼
Clearside Biomedical has not had any recent stock splits.
Where is Clearside Biomedical headquartered?▼
Clearside Biomedical is headquartered in Alpharetta, United States.